Rigel Pharmaceuticals | RIGL - Interest Income


Rigel Pharmaceuticals reported $0.7 in Interest Income for its fiscal quarter ending in September of 2024.





Interest Income Change Date
Arrowhead Research USD 16.93M 66K Jun/2026
AstraZeneca USD 80M 7M Jun/2026
BioMarin Pharmaceutical USD 4.63M 5.85M Sep/2026
Daiichi Sankyo JPY 9.74B 217M Jun/2026
Eli Lilly USD 65M 25M Sep/2025
Heron Therapeutics USD 433K 277K Dec/2021
Intrexon USD 319K 602K Jun/2024
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
Ligand Pharmaceuticals USD 7.3M 643K Jun/2026
MacroGenics USD 1.37M 186K Jun/2026
Pfizer USD 0.56 0.6 Sep/2026
Regeneron Pharmaceuticals USD 183.3M 200K Jun/2026
Rigel Pharmaceuticals USD 0.7 0.76 Sep/2024
Ultragenyx Pharmaceutical USD 5M 1000K Jun/2026
Veracyte USD 3.88M 406K Jun/2026